Catalyst Wire Dossier Catalyst Wire Dossier

SYMFI

EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE · Viatris Specialty LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SYMFI, covering 2018-03-22 to 2019-10-29. Get the full timeline:

Most recent: FDA Approved: SYMFI — Supplemental Application (Viatris Specialty LLC)

See pricing